Linked Data API

Show Search Form

Search Results

765283
registered interest false more like this
date less than 2017-10-06more like thismore than 2017-10-06
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Transplant Surgery: Stem Cells more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to improve access to psychological support for patients recovering from a stem cell transplant. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 105451 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-10-16more like thismore than 2017-10-16
answer text <p>The impact of cancer continues beyond the initial treatment. Patients may experience physical, financial, social and psychological issues.</p><p> </p><p>NHS England are rolling out the Recovery Package, which will ensure patients have more personal care and support from the point they are diagnosed and once treatment ends. For patients this means working with their care team to develop a comprehensive plan outlining their physical needs and other support they may need, such as help at home or financial advice.</p><p> </p><p>By 2020 NHS England wants all cancer patients to have access to the Recovery Package and is committed to implementing this in collaboration with charities, professionals and patients themselves.</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2017-10-16T15:28:04.42Zmore like thismore than 2017-10-16T15:28:04.42Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
3960
label Biography information for Henry Smith more like this
765286
registered interest false more like this
date less than 2017-10-06more like thismore than 2017-10-06
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Transplant Surgery: Stem Cells more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will discuss with NHS England the necessity for a review of the care and support that patients receive after a stem cell transplant. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 105453 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-10-16more like thismore than 2017-10-16
answer text <p>Post-transplant care for patients is important. NHS England’s Specialised Commissioning team and Clinical Reference Group for Blood and Marrow Transplants (BMT) are undertaking work to map care needs post-100 days.</p><p> </p><p>There are no current plans to review the responsibilities of services commissioned by NHS England and clinical commissioning groups (CCGs) for BMT at this time. NHS England will be assessing BMT in more detail over the next 18 months and will take the opportunity to further support improved pathway planning and commissioning of services that it and CCGs fund.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2017-10-16T16:36:57.657Zmore like thismore than 2017-10-16T16:36:57.657Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
765287
registered interest false more like this
date less than 2017-10-06more like thismore than 2017-10-06
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Transplant Surgery: Stem Cells more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, for what reason responsibility for commissioning services following a stem cell transplant from NHS England to clinical commissioning groups after 100 days. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 105452 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-10-16more like thismore than 2017-10-16
answer text <p>The Manual for Prescribed Specialised Services describes which elements of specialised services are commissioned by NHS England and which are commissioned by clinical commissioning groups (CCGs):</p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2017/10/prescribed-specialised-services-manual-2.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2017/10/prescribed-specialised-services-manual-2.pdf</a></p><p>Due to the small number of patients involved, the cost of the transplant episode and the small number of transplant experts, Blood and Bone Marrow Transplantation (BMT) is defined as a prescribed specialised service. NHS England is responsible for commissioning and funding the transplant related care which takes place 30 days before transplant and continues until 100 days post-transplant. After 100 days post-transplant, commissioning responsibility for the routine follow-up of patients switches from NHS England to CCGs, as outlined in the Manual.</p><p>In the event that transplant patients experience serious complications post-transplant, elements of their care would likely continue to be planned, organised and funded by NHS England specialised commissioning. For example, if a patient requires Extracorporeal Photopheresis which is a treatment for acute and chronic graft versus host disease following transplantation, NHS England commissions this care post-transplant.</p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2017-10-16T16:39:07.627Zmore like thismore than 2017-10-16T16:39:07.627Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
746126
registered interest false more like this
date less than 2017-06-28more like thismore than 2017-06-28
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, when he expects the Cancer Transformation Fund to be made available to support the Cancer Recovery Package and the cancer stratified follow-up pathways. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 1543 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-07-04more like thismore than 2017-07-04
answer text <p>In December 2016, Cancer Alliances were invited to submit bids against a £200 million transformation fund (for 2017/18 and 2018/19) to support delivery of early diagnosis and implementation of the Recovery Package and stratified follow-up pathways. Based on an assessment of the bids, NHS England has decided to take a phased approach to releasing the funding over the course of 2017/18.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2017-07-04T11:22:52.32Zmore like thismore than 2017-07-04T11:22:52.32Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
3960
label Biography information for Henry Smith more like this
720556
registered interest false more like this
date less than 2017-04-13more like thismore than 2017-04-13
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, when he expects the recently established cancer delivery plans to be published. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 70573 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-04-25more like thismore than 2017-04-25
answer text <p>Currently there is no co-ordinated date for publication of cancer delivery plans.</p> more like this
answering member constituency Warrington South more like this
answering member printed David Mowat more like this
question first answered
less than 2017-04-25T15:32:03.57Zmore like thismore than 2017-04-25T15:32:03.57Z
answering member
4080
label Biography information for David Mowat more like this
tabling member
3960
label Biography information for Henry Smith more like this
686153
registered interest false more like this
date less than 2017-02-07more like thismore than 2017-02-07
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Brentuximab Vedotin more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to ensure relapsed and refractory Hodgkin lymphoma patients continue to have access to brentuximab vedotin. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 63498 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-02-15more like thismore than 2017-02-15
answer text <p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) provides independent, evidence-based guidance for the National Health Service on whether drugs and treatments represent a clinically and cost effective use of NHS resources. NICE is appraising Brentuximab for this indication and recently consulted stakeholders on its draft recommendations. Brentuximab is currently available to NHS patients with relapsed and refractory Hodgkin lymphoma through the Cancer Drugs Fund.</p> more like this
answering member constituency Oxford West and Abingdon more like this
answering member printed Nicola Blackwood more like this
question first answered
less than 2017-02-15T13:39:18.99Zmore like thismore than 2017-02-15T13:39:18.99Z
answering member
4019
label Biography information for Baroness Blackwood of North Oxford more like this
tabling member
3960
label Biography information for Henry Smith more like this
678626
registered interest false more like this
date less than 2017-01-25more like thismore than 2017-01-25
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Health Services: Foreign Nationals more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what recent progress his Department has made on recovering money from overseas visitors and other chargeable NHS patients. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 61532 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-02-02more like thismore than 2017-02-02
answer text <p>The National Health Service is a national, not an international, service. This Government was the first to introduce tough measures to clamp down on migrants accessing free NHS care, including introducing the immigration health surcharge.</p><p> </p><p>The initiatives we have implemented have meant the income identified from visitors and migrants has trebled from £89 million in 2012/13 to £289 million in 2015/16.</p> more like this
answering member constituency Ludlow more like this
answering member printed Mr Philip Dunne more like this
question first answered
less than 2017-02-02T13:35:40.177Zmore like thismore than 2017-02-02T13:35:40.177Z
answering member
1542
label Biography information for Philip Dunne more like this
tabling member
3960
label Biography information for Henry Smith more like this
671782
registered interest false more like this
date less than 2017-01-11more like thismore than 2017-01-11
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, with reference to NHS England's announcement on 6 December 2016 of an additional £200 million to improve local cancer services, what plans he has to ensure that that money will be used to roll out the Recovery Package and stratified pathways of follow-up care as costed in the Independent Cancer Taskforce report. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 59671 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-01-19more like thismore than 2017-01-19
answer text <p>The £200 million fund NHS England announced in December 2016 will be available to Cancer Alliances over the next two years to specifically support the areas the Cancer Taskforce strategy estimated would need additional investment including implementing the Recovery Package and rolling out stratified follow up pathways.</p><p> </p><p>Initial bids for funding are due on 18 January 2017. Clear guidance has been published and a regional and national panel will assess all bids received. The funding will be signed off by the NHS England Investment Committee.</p> more like this
answering member constituency Warrington South more like this
answering member printed David Mowat more like this
question first answered
less than 2017-01-19T11:56:42.413Zmore like thismore than 2017-01-19T11:56:42.413Z
answering member
4080
label Biography information for David Mowat more like this
tabling member
3960
label Biography information for Henry Smith more like this
528906
registered interest false more like this
date less than 2016-06-27more like thismore than 2016-06-27
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Blood Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the findings of the National Cancer Patient Experience Survey 2015 on the proportion of blood cancer patients who visited their GP more than twice before being referred to secondary care for diagnosis; and what support and guidance his Department has provided to GPs to enable them to identify the symptoms of blood cancer. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 41284 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2016-07-05more like thismore than 2016-07-05
answer text <p>It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.</p><p> </p><p>The independent Cancer Taskforce published its report <em>Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020</em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published <em>Achieving World-Class Cancer Outcomes:</em> <em>Taking the Strategy Forward</em> outlining the detailed steps being taken to make this a reality.</p><p> </p><p>In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.</p><p> </p><p>In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:</p><p> </p><p><a href="http://www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" target="_blank">www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines</a></p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
grouped question UIN
41285 more like this
41329 more like this
question first answered
less than 2016-07-05T15:11:22.383Zmore like thismore than 2016-07-05T15:11:22.383Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
3960
label Biography information for Henry Smith more like this
528907
registered interest false more like this
date less than 2016-06-27more like thismore than 2016-06-27
answering body
Department of Health more like this
answering dept id 17 remove filter
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Cancer: Health Education more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of blood cancer and other cancers for which symptoms can be non-specific and have similarities to other benign conditions. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 41283 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2016-07-05more like thismore than 2016-07-05
answer text <p>Public Health England’s (PHE) Be Clear on Cancer campaigns are designed to raise the public’s awareness of specific cancer symptoms, encourage people with those symptoms to go to the doctor and diagnose cancer at an earlier stage. These campaigns are delivered by PHE in partnership with the Department and NHS England.</p><p> </p><p>The decision on which cancers should be the focus of ‘Be Clear on Cancer’ campaigns is informed by a steering group, whose members include primary and secondary care clinicians, and key voluntary sector organisations.</p><p> </p><p>A number of factors are taken into account when deciding which campaigns to develop and run, with one of the main criteria being the scope to save lives through earlier diagnosis and whether the cancer has a clear early sign or symptom that the general public can act upon should it arise. There are a number of cancers, including those for which symptoms can be non-specific, which are not covered by ‘Be Clear on Cancer’ specifically.</p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2016-07-05T15:10:26.383Zmore like thismore than 2016-07-05T15:10:26.383Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
3960
label Biography information for Henry Smith more like this